Health Care • Misc Health and Biotechnology Services
$23.13 ▲ +0.51
(+2.26%)
MKT CAP: $12.92B • VOL: 1.36M
52W L $20 52W H $27
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$19
MEDIAN
$26
MEAN
$26
HIGH
$31
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE FMS TAPE
FMS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $27.99 | $26.60 | 2025-02-14 | $21.05 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $29.14 | $27.29 | 2025-02-06 | $21.74 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $26.37 | $25.44 | 2025-01-29 | $22.20 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $23.59 | — | 2025-01-17 | $22.67 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $20.35 | $21.97 | 2025-01-09 | $20.59 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $27.52 | $24.06 | 2024-12-18 | $20.12 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $22.44 | $23.36 | 2024-12-04 | $21.51 | -4.3% | 48% | C |